PARVOVIRUS B19 PROMOTER AT MAP UNIT-6 CONFERS AUTONOMOUS REPLICATION COMPETENCE AND ERYTHROID SPECIFICITY TO ADENOASSOCIATED VIRUS-2 IN PRIMARY HUMAN HEMATOPOIETIC PROGENITOR CELLS
Xs. Wang et al., PARVOVIRUS B19 PROMOTER AT MAP UNIT-6 CONFERS AUTONOMOUS REPLICATION COMPETENCE AND ERYTHROID SPECIFICITY TO ADENOASSOCIATED VIRUS-2 IN PRIMARY HUMAN HEMATOPOIETIC PROGENITOR CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(26), 1995, pp. 12416-12420
The pathogenic human parvovirus B19 is an autonomously replicating vir
us with a remarkable tropism for human erythroid progenitor cells, Alt
hough the target cell specificity for B19 infection has been suggested
to be mediated by the erythrocyte P-antigen receptor (globoside), a n
umber of nonerythroid cells that express this receptor are nonpermissi
ve for B19 replication, To directly test the role of expression from t
he B19 promoter at map unit 6 (B19p6) in the erythroid cell specificit
y of B19, we constructed a recombinant adenoassociated virus 2 (AAV),
in which the authentic AAV promoter at map unit 5 (AAVp5) was replaced
by the B19p6 promoter, Although the wild-type (wt) AAV requires a hel
per virus for its optimal replication, we hypothesized that inserting
the B19p6 promoter in a recombinant AAV would permit autonomous viral
replication, but only in erythroid progenitor cells. In this report, w
e provide evidence that the B19p6 promoter is necessary and sufficient
to impart autonomous replication competence and erythroid specificity
to AAV in primary human hematopoietic progenitor cells, Thus, express
ion from the B19p6 promoter plays an important role in post-P-antigen
receptor erythroid-cell specificity of parvovirus B19. The AAV-B19 hyb
rid vector system may also prove to be useful in potential gene therap
y of human hemoglobinopathies.